WHO Covid Vaccine Revised Roadmap April 3, 2023 Unipro2013main Covid Scandal, Covid19 </p> <h2>WHO’s Strategic Advisory Group of Experts (people who are good at stuff)</h2> <p> revised the roadmap for prioritizing the use of COVID-19 vaccines,<br /> to reflect the impact of Omicron and high population-level immunity due to infection and vaccination.</p> <p>The roadmap newly considers the cost-effectiveness of COVID-19 vaccination for those at lower risk<br /> – namely healthy children and adolescents –</p> <p>Revised roadmap reemphasizes the importance of vaccinating those still at-risk of severe disease,<br /> mostly older adults and those with underlying conditions,</p> <p>Chair Dr Hanna Nohynek.</p> <p>“Countries should consider their specific context in deciding whether to continue vaccinating low risk groups,</p> <p>like healthy children and adolescents,</p> <p>while not compromising the routine vaccines that are so crucial for the health and well-being of this age group.”</p> <p>The high priority group</p> <p>and frontline health workers.</p> <p>SAGE recommends an additional booster of either 6 or 12 months after the last dose,</p> <p>Medium priority group</p> <p>healthy adults – usually under the age of 50-60 – without comorbidities</p> <p>Although additional boosters are safe for this group, SAGE does not routinely recommend them,</p> <p>The low priority group</p> <p>healthy children and adolescents aged 6 months to 17 years.</p> <p>Primary and booster doses are safe and effective in children and adolescents.</p> <p>The public health impact of vaccinating healthy children and adolescents is comparatively much lower than the established benefits of traditional essential vaccines for children</p> <p>Vaccinating pregnant persons – including with an additional dose if more than 6 months have passed since the last dose – protects both them and the fetus</p> <p>Other meeting highlights include:</p> <p>Polio, OPV</p> <p>Regional reports on measles</p> <p>With measles cases increasing in all WHO regions in 2022</p> <p>In 2021, with 25 million children missing out.</p> <p>Status of new tuberculosis vaccines</p> <p>Tuberculosis (TB) is a leading cause of death and a vaccine that prevents disease in adolescents and adults is urgently needed.</p> <p>A substantial effort for vaccine development is underway, with several candidates in late-stage clinical trials</p> <p>Malaria</p> <p>Introducing the RTS,S malaria vaccine has resulted in a substantial reduction in severe malaria and all-cause mortality among age eligible children.<br /> <br /> Credit to :</p> <p> Please support our Sponsors here :
